The Democratic Republic of the Congo's (DRC's) ministry of health confirmed that the new Ebola outbreak in the eastern reaches of the country is caused by the Zaire Ebola virus species, according to Science magazine.
The DRC says 4 people in the eastern part of the country tested positive for Ebola virus.
The Democratic Republic of Congo (DRC) health ministry announced yesterday that it has received reports of 25 fever cases with symptoms similar to Ebola in North Kivu province in the eastern part of the country.
In a statement, it said the affected area is in the Mangina health district.
It's not known if the new Bombali virus can spread to people, but it has the potential to enter human cells.
In an update yesterday that came a day after the Democratic Republic of Congo's (DRC's) Ebola outbreak was declared over, the World Health Organization (WHO) said it now considers the risk to the region and the rest of the world as low.
The declaration comes just 11 weeks after health officials sounded the alarm about the outbreak in early May.
The Liberian case from 2015 highlights a lingering threat that the DRC will face after its outbreak is declared over.
Public Health England (PHE) yesterday released its provisional seasonal flu vaccine effectiveness (VE) estimates for the 2017-18 flu season, which revealed low overall effectiveness and no protection against H3N2, but variable findings in different age-groups.
A phase 3 study of the novel antiviral baloxavir marboxil suggests that it reduces symptoms in people at high risk of flu complications, Roche announced today.
The US Food and Drug Administration (FDA) today approved TPOXX (tecovirimat), made by SIGA Technologies, as the first drug with an indication for treating smallpox, a disease that has been eradicated but could still be used as a bioweapon.
